Increasing Universal Lipid Screening Among 9- to 11-Year-Old Children Through a Quality Improvement Initiative

Area of Science:

• Pediatrics
• Public Health
• Quality Improvement

Background:

• The National Heart Lung and Blood Institute recommended universal lipid screening (ULS) for children aged 9-11 in 2011.
• Assessing the effectiveness of quality improvement (QI) initiatives in enhancing pediatric screening practices is crucial.

Purpose of the Study:

• To evaluate the impact of a QI initiative on the implementation of ULS in children aged 9-11.
• To understand physician perspectives on ULS and its associated challenges.

Main Methods:

• Retrospective analysis of electronic medical records comparing screening rates pre- and post-QI implementation.
• Focus group discussions with physicians to explore attitudes towards ULS.
• Inclusion of children aged 9-11 attending well-child checks.

Main Results:

• The QI initiative significantly increased ULS ordering in its first phase (64.3% increase, P < .001), with a minimal increase in the second phase (2.3%, P = .75).
• The prevalence of abnormal lipid screening results remained consistent between pre- and post-intervention periods (21.4% vs 20.1%, P = .91).
• Physicians acknowledged some benefits but raised concerns regarding cost-effectiveness and the long-term health impact of ULS.

Conclusions:

• The QI initiative was effective in achieving high rates of ULS in the target pediatric population.
• Physician skepticism regarding the long-term benefits and cost-effectiveness of ULS persists.
• Further research is warranted to investigate the comprehensive benefits, costs, and long-term outcomes associated with ULS in children.